Citadel Advisors’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.17M Sell
2,611,345
-531,746
-17% -$1.7M 0.01% 3375
2025
Q4
$8.58M Sell
3,143,091
-677,273
-18% -$1.57M 0.01% 3459
2025
Q3
$8.29M Sell
3,820,364
-293,224
-7% -$692K 0.01% 3545
2025
Q2
$7.08M Buy
4,113,588
+2,380,785
+137% +$5.92M 0.01% 3535
2025
Q1
$5.77M Buy
1,732,803
+639,199
+58% +$3.3M 0.01% 3651
2024
Q4
$8.09M Buy
1,093,604
+69,768
+7% +$647K 0.01% 3252
2024
Q3
$9.61M Buy
1,023,836
+780,578
+321% +$7.4M 0.01% 2953
2024
Q2
$1.95M Sell
243,258
-867,739
-78% -$9.3M ﹤0.01% 5365
2024
Q1
$16.5M Buy
1,110,997
+824,963
+288% +$9.6M 0.02% 2294
2023
Q4
$2.33M Sell
286,034
-103,101
-26% -$539K ﹤0.01% 5102
2023
Q3
$1.77M Sell
389,135
-945,312
-71% -$6.17M ﹤0.01% 5444
2023
Q2
$9.39M Sell
1,334,447
-2,137,584
-62% -$15.3M 0.01% 2763
2023
Q1
$21.2M Buy
3,472,031
+1,177,989
+51% +$8.13M 0.02% 1861
2022
Q4
$14.7M Buy
2,294,042
+1,862,210
+431% +$14.5M 0.02% 2327
2022
Q3
$4.14M Sell
431,832
-2,089,992
-83% -$24.1M 0.01% 4193
2022
Q2
$27.8M Buy
2,521,824
+2,386,618
+1,765% +$31.3M 0.04% 1524
2022
Q1
$2.25M Sell
135,206
-110,752
-45% -$1.71M ﹤0.01% 5826
2021
Q4
$4.7M Sell
245,958
-1,107,605
-82% -$24.4M 0.01% 4406
2021
Q3
$33.4M Sell
1,353,563
-1,024,101
-43% -$24.1M 0.04% 1472
2021
Q2
$61.9M Buy
2,377,664
+1,621,945
+215% +$42.2M 0.06% 960
2021
Q1
$23.9M Sell
755,719
-570,173
-43% -$23.6M 0.03% 1752
2020
Q4
$61.5M Buy
1,325,892
+34,494
+3% +$1.37M 0.07% 810
2020
Q3
$42.5M Sell
1,291,398
-549,748
-30% -$16.9M 0.06% 972
2020
Q2
$50.5M Buy
1,841,146
+1,432,331
+350% +$47.1M 0.07% 790
2020
Q1
$12.2M Buy
408,815
+103,031
+34% +$2.73M 0.02% 1657
2019
Q4
$8.46M Buy
305,784
+220,465
+258% +$5.01M 0.01% 2398
2019
Q3
$1.55M Sell
85,319
-217,528
-72% -$4.81M ﹤0.01% 4873
2019
Q2
$7.43M Sell
302,847
-1,636,021
-84% -$24.6M 0.01% 2545
2019
Q1
$18.4M Sell
1,938,868
-2,488,645
-56% -$24.2M 0.02% 1413
2018
Q4
$39.2M Buy
4,427,513
+1,126,352
+34% +$10.9M 0.06% 757
2018
Q3
$37.1M Buy
3,301,161
+2,841,526
+618% +$40.3M 0.04% 931
2018
Q2
$5.88M Buy
459,635
+264,160
+135% +$3.86M 0.01% 2551
2018
Q1
$3.3M Buy
195,475
+163,531
+512% +$2.48M 0.01% 3008
2017
Q4
$256K Sell
31,944
-23,380
-42% -$188K ﹤0.01% 6706
2017
Q3
$429K Buy
+55,324
New +$350K ﹤0.01% 5544
2017
Q2
Sell
-53,562
Closed -$399K 7804
2017
Q1
$399K Buy
53,562
+12,806
+31% +$93.9K ﹤0.01% 5403
2016
Q4
$283K Sell
40,756
-5,984
-13% -$41.2K ﹤0.01% 5763
2016
Q3
$385K Buy
46,740
+27,086
+138% +$229K ﹤0.01% 5261
2016
Q2
$159K Buy
19,654
+7,021
+56% +$44.1K ﹤0.01% 5986
2016
Q1
$64K Sell
12,633
-21,678
-63% -$119K ﹤0.01% 6183
2015
Q4
$265K Buy
+34,311
New +$238K ﹤0.01% 5402
2015
Q3
Sell
-63,781
Closed -$585K 9062
2015
Q2
$585K Buy
+63,781
New +$712K ﹤0.01% 4722

Other funds holding IOVA